Hypertension and kidney dysfunction despite long-term remission of Cushing’s syndrome
Authors:
- 29 July 2025
- journal article
- Published by Springer Nature in Journal of Endocrinological Investigation
- Vol. 48 (11) , 2671-2681
Abstract
Hypertension is the most frequent co-morbidity in active Cushing's syndrome (CS) and regarded as a major cardio-vascular risk factor. It is unknown whether blood pressure and related parameters, such as kidney function, recover in the long-term following remission of CS. Blood pressure and related co-morbidities were analyzed in a cohort of 81 patients with CS (Cushing's disease: 52, ectopic CS: 8, adrenal CS: 21) from a single tertiary care center. Patients were longitudinally evaluated at baseline, at 7.1 years (6.3-7.4) and at 14 years (13.5-14.4) after biochemical remission. Data were compared to a control group matched for BMI, age and sex (n = 243) from the "Cooperative Health Research in the Region of Augsburg" study (KORA) in a 1:3 fashion. Patients with CS showed a higher median blood pressure and lower median glomerular filtration rate (GFR) compared to the matched controls, at baseline, 7 and 14 years after biochemical remission. Although the prevalence of hypertension and chronic kidney disease increased over time in the KORA cohort, patients treated for CS had a significantly higher prevalence of both comorbidities. Notably, the number of patients on antihypertensive medication declined in the Cushing's cohort, resulting in significantly higher rates of uncontrolled hypertension at follow-up. The prevalence of hypertension and impaired kidney function remained elevated in patients with CS years after biochemical remission, potentially contributing to an unfavorable long-term clinical outcome. This highlights the critical need for increased monitoring and treatment of co-morbidities in patients with CS following surgical remission.Keywords
Funding Information
- Else Kröner-Fresenius-Stiftung (2012_A103 and 2015_A228, RISE, RISE)
- Deutsche Forschungsgemeinschaft (314061271-TRR 205, 314061271-TRR 205, 413635475)
- Bundesministerium für Bildung, Wissenschaft, Forschung und Technologie (BMBF FKZ 01ET0713 and 01ET1003A, BMBF FKZ 01ET0713 and 01ET1003A, BMBF FKZ 01ET0713 and 01ET1003A)
This publication has 24 references indexed in Scilit:
- Diurnal pattern of salivary cortisol and progression of aortic stiffness: Longitudinal studyPsychoneuroendocrinology, 2021
- Consensus on diagnosis and management of Cushing's disease: a guideline updateThe Lancet Diabetes & Endocrinology, 2021
- Arterial hypertensionThe Lancet, 2021
- Postoperative renal impairment and longitudinal change in renal function after adrenalectomy in patients with Cushing's syndromeInternational Journal of Urology, 2020
- Remission of hypertension after surgical cure of Cushing's syndromeClinical Endocrinology, 2019
- Factors predicting long-term comorbidities in patients with Cushing’s syndrome in remissionEndocrine, 2018
- Association of hypertension cut-off values with 10-year cardiovascular mortality and clinical consequences: a real-world perspective from the prospective MONICA/KORA studyEuropean Heart Journal, 2018
- Relative fat mass (RFM) as a new estimator of whole-body fat percentage ─ A cross-sectional study in American adult individualsScientific Reports, 2018
- The role of obesity in the pathogenesis of hypertensionNature Clinical Practice Nephrology, 2008
- Results and long-term follow-up after unilateral adrenalectomy for ACTH-independent hypercortisolism in a series of fifty patientsJournal of Endocrinological Investigation, 2005